| Ms Jessica A Feldman, MD | |
|
920 Lawn Ave, The Summit - Suite 5, Sellersville, PA 18960-1560 | |
| (215) 257-4900 | |
| (215) 257-6681 |
| Full Name | Ms Jessica A Feldman |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 22 Years |
| Location | 920 Lawn Ave, Sellersville, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881647808 | NPI | - | NPPES |
| 1015476100001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | MD425077 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grand View Hospital | Sellersville, PA | Hospital |
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Doylestown Hospital | Doylestown, PA | Hospital |
| St Lukes Quakertown Hospital | Quakertown, PA | Hospital |
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steffie Enterprises, Inc | 0840225736 | 354 |
| Clinical Care Associates Of The University Of Pennsylvania Health | 4688588866 | 517 |
News Archive
Hospice Foundation of America is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services, and can be found at www.hospicefoundation.org/infocenter.
OPKO Health, Inc. today announced that it has entered into a definitive agreement with Schering-Plough Corporation to acquire assets relating to Schering's neurokinin-1 (NK-1) receptor antagonist program. Rolapitant, the lead product, recently completed Phase II clinical testing for prevention of nausea and vomiting related to cancer chemotherapy and surgery, and other indications.
Buffalo Grove, Illinois-based specialty-oncology drug development company, Meridian Laboratories, Inc (Meridian) held a Type B Pre-Investigational New Drug (pre-IND) meeting with the FDA Center for Drug Evaluation Research, Division of Oncology Products on Wednesday January 23, 2013 to discuss its plan to commence clinical development of ML061, Meridian's lead product, as a treatment for various types of cancer.
With new information from Melbourne's Peter MacCallum Cancer Centre revealing that some complementary medicines can interact with cancer treatment, NPS MedicineWise reminds all Australians that complementary medicines can cause side effects, and interact with other over-the-counter and prescription medicines.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has received approval from the U.S. Food and Drug Administration for Dyloject (diclofenac sodium) Injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic.
› Verified 6 days ago
| Entity Name | Clinical Care Associates Of The University Of Pennsylvania Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972682995 PECOS PAC ID: 4688588866 Enrollment ID: O20031113000301 |
News Archive
Hospice Foundation of America is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services, and can be found at www.hospicefoundation.org/infocenter.
OPKO Health, Inc. today announced that it has entered into a definitive agreement with Schering-Plough Corporation to acquire assets relating to Schering's neurokinin-1 (NK-1) receptor antagonist program. Rolapitant, the lead product, recently completed Phase II clinical testing for prevention of nausea and vomiting related to cancer chemotherapy and surgery, and other indications.
Buffalo Grove, Illinois-based specialty-oncology drug development company, Meridian Laboratories, Inc (Meridian) held a Type B Pre-Investigational New Drug (pre-IND) meeting with the FDA Center for Drug Evaluation Research, Division of Oncology Products on Wednesday January 23, 2013 to discuss its plan to commence clinical development of ML061, Meridian's lead product, as a treatment for various types of cancer.
With new information from Melbourne's Peter MacCallum Cancer Centre revealing that some complementary medicines can interact with cancer treatment, NPS MedicineWise reminds all Australians that complementary medicines can cause side effects, and interact with other over-the-counter and prescription medicines.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has received approval from the U.S. Food and Drug Administration for Dyloject (diclofenac sodium) Injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jessica A Feldman, MD 920 Lawn Ave, The Summit - Suite 5, Sellersville, PA 18960-1560 Ph: (215) 257-4900 | Ms Jessica A Feldman, MD 920 Lawn Ave, The Summit - Suite 5, Sellersville, PA 18960-1560 Ph: (215) 257-4900 |
News Archive
Hospice Foundation of America is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services, and can be found at www.hospicefoundation.org/infocenter.
OPKO Health, Inc. today announced that it has entered into a definitive agreement with Schering-Plough Corporation to acquire assets relating to Schering's neurokinin-1 (NK-1) receptor antagonist program. Rolapitant, the lead product, recently completed Phase II clinical testing for prevention of nausea and vomiting related to cancer chemotherapy and surgery, and other indications.
Buffalo Grove, Illinois-based specialty-oncology drug development company, Meridian Laboratories, Inc (Meridian) held a Type B Pre-Investigational New Drug (pre-IND) meeting with the FDA Center for Drug Evaluation Research, Division of Oncology Products on Wednesday January 23, 2013 to discuss its plan to commence clinical development of ML061, Meridian's lead product, as a treatment for various types of cancer.
With new information from Melbourne's Peter MacCallum Cancer Centre revealing that some complementary medicines can interact with cancer treatment, NPS MedicineWise reminds all Australians that complementary medicines can cause side effects, and interact with other over-the-counter and prescription medicines.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has received approval from the U.S. Food and Drug Administration for Dyloject (diclofenac sodium) Injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic.
› Verified 6 days ago
Madeline Louise Singer, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 920 Lawn Ave Ste 5, Sellersville, PA 18960 Phone: 215-257-4900 Fax: 215-257-6681 | |
Wei Zheng, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 920 Lawn Ave, Suite 5, Sellersville, PA 18960 Phone: 215-257-4900 Fax: 215-257-6681 | |
Jennifer B Sokol, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551 Fax: 215-257-9347 | |
Dr. James G Showalter, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551 Fax: 215-257-9347 | |
Scott Myers Harman, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551 Fax: 215-257-9347 | |
Anishee Shah Undavia, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 920 Lawn Ave, Suite 5, Sellersville, PA 18960 Phone: 215-257-1209 | |
Tamoor Ilyas, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551 |